stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) EV/FCF
As of 5 November 2026, DENTSPLY SIRONA Inc. (XRAY) trades at a EV/FCF of 40.0×. Over the past ten years it has ranged from 13.5× (April 2025) to 57.1× (October 2025); the current reading is higher than 85% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 40.1× | 113.95% |
| FY2024 | 18.7× | (53.66%) |
| FY2023 | 40.4× | 72.54% |
| FY2022 | 23.4× | (13.14%) |
| FY2021 | 27.0× | 15.43% |
| FY2020 | 23.4× | (12.53%) |
| FY2019 | 26.7× | (10.67%) |
| FY2018 | 29.9× | (17.88%) |
| FY2017 | 36.4× | 14.51% |
| FY2016 | 31.8× | 42.73% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 37.4× | 37.10% |
| Jun 2026 | 27.3× | (34.65%) |
| Mar 2026 | 41.8× | 4.20% |
| Dec 2025 | 40.1× | (28.18%) |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. compare | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| KMTS Kestra Medical Technologies, Ltd. compare | −12.3× |
| LMAT LeMaitre Vascular, Inc. compare | 25.1× |
| XRAY DENTSPLY SIRONA Inc. | 40.0× |
| STAA STAAR Surgical Company compare | 65.4× |
| ATRC AtriCure, Inc. compare | 125× |
| WRBY Warby Parker Inc. compare | 139× |
| AZTA Azenta, Inc. compare | 144× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement